Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

被引：0
|
作者：
Park, S. H. [1 ]
Amissi, S. [1 ]
Algara-Suarez, P. [1 ]
Gong, D. S. [1 ]
Mroueh, A. [1 ]
Belcastro, E. [1 ]
Matsushita, K. [1 ]
Bruckert, C. [1 ]
Chaker, A. B. [1 ]
Jesel, L. [2 ]
Ohlmann, P. [2 ]
Morel, O. [2 ]
Mazzucotelli, J. P. [2 ]
Schini-Kerth, V. B. [1 ]
机构：
[1] Univ Strasbourg, INSERM UMR 1260, Regenerat Nanomed, Strasbourg, France
[2] Univ Hosp Strasbourg, Cardiol, Strasbourg, France
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3440 / 3440
页数：1
相关论文
共 50 条
  • [41] Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients
    Ibrahim, Nasrien E.
    Januzzi, James L., Jr.
    CLINICAL CHEMISTRY, 2021, 67 (01) : 79 - 86
  • [42] Acute abdomen as a side-effect of sodium-glucose co-transporter 2 inhibitors in diabetic patients
    Kietaibl, Antonia-Therese
    Fasching, Peter
    Glaser, Karl
    Petter-Puchner, Alexander H.
    BRITISH JOURNAL OF SURGERY, 2021, 108 (12) : E409 - E409
  • [43] Value of Sodium-Glucose Co-Transporter 2 Inhibitor Versus Traditional Medication in Microalbuminuric Diabetic Patients
    Hussein, Nahla
    Abdelrahman, Fatma
    Khedr, Abdelrahman
    Aref, Hayam
    Halawa, Mohamed Reda
    ElSharkawy, Magdy
    CURRENT DIABETES REVIEWS, 2021, 17 (06)
  • [44] Effect of sodium-glucose co-transporter inhibitors on arterial stiffness in patients with type 2 diabetes mellitus
    Szigeti, J.
    Bukva, M.
    Gaszner, B.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] Association of Eligibility for a Sodium-Glucose Co-Transporter 2 Inhibitor and Cardiovascular Outcomes in Patients with Atrial Fibrillation
    Oraii, Alireza
    Healey, Jeff S.
    Fonguh, Sylvanus
    Wang, Jia
    Pandey, Arjun K.
    Conen, David
    Connolly, Stuart J.
    McIntyre, William F.
    CIRCULATION, 2021, 144
  • [46] Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy
    Chen, Hui
    Zhang, Xiongze
    Liao, Nanying
    Ji, Yuying
    Mi, Lan
    Gan, Yuhong
    Su, Yongyue
    Wen, Feng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [47] Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
    Jeon, Ja Young
    Kim, Dae Jung
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05) : 837 - 846
  • [48] Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
    Takahara, Mitsuyoshi
    Soga, Yoshimitsu
    Fujihara, Masahiko
    Iida, Osamu
    Kawasaki, Daizo
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [49] Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
    Mitsuyoshi Takahara
    Yoshimitsu Soga
    Masahiko Fujihara
    Osamu Iida
    Daizo Kawasaki
    Cardiovascular Diabetology, 22
  • [50] The role of sodium-glucose co-transporter 2 protein inhibitors in heart failure: more than an antidiabetic drug?
    Savarimuthu, Sugeevan
    Harky, Amer
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 377 - 386
12345